Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

1.

Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.

Modiano JF, Sun J, Lang J, Vacano G, Patterson D, Chan D, Franzusoff A, Gianani R, Meech SJ, Duke R, Bellgrau D.

Clin Immunol. 2004 Jul;112(1):54-65.

PMID:
15207782
[PubMed - indexed for MEDLINE]
2.

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

Zhang H, Yang Y, Horton JL, Samoilova EB, Judge TA, Turka LA, Wilson JM, Chen Y.

J Clin Invest. 1997 Oct 15;100(8):1951-7.

PMID:
9329958
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.

Cippitelli M, Fionda C, Di Bona D, Di Rosa F, Lupo A, Piccoli M, Frati L, Santoni A.

J Immunol. 2002 Feb 1;168(3):1154-66.

PMID:
11801650
[PubMed - indexed for MEDLINE]
Free Article
4.

Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.

Zeytun A, Hassuneh M, Nagarkatti M, Nagarkatti PS.

Blood. 1997 Sep 1;90(5):1952-9.

PMID:
9292529
[PubMed - indexed for MEDLINE]
Free Article
5.

T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells.

Tada Y, O-Wang J, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M.

Int J Mol Med. 2002 Mar;9(3):281-5.

PMID:
11836634
[PubMed - indexed for MEDLINE]
6.

Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.

Lombard C, McKallip RJ, Hylemon PB, Nagarkatti PS, Nagarkatti M.

Clin Immunol. 2003 Nov;109(2):144-53.

PMID:
14597213
[PubMed - indexed for MEDLINE]
7.

Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.

Pinkoski MJ, Droin NM, Lin T, Genestier L, Ferguson TA, Green DR.

Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16174-9. Epub 2002 Nov 26.

PMID:
12454289
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.

Hoves S, Krause SW, Halbritter D, Zhang HG, Mountz JD, Schölmerich J, Fleck M.

J Immunol. 2003 Jun 1;170(11):5406-13.

PMID:
12759415
[PubMed - indexed for MEDLINE]
Free Article
9.

Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL.

Kim SH, Kim S, Oligino TJ, Robbins PD.

Mol Ther. 2002 Nov;6(5):584-90.

PMID:
12409256
[PubMed - indexed for MEDLINE]
10.

Specific deletion of autoreactive T cells by adenovirus-transfected, Fas ligand-producing antigen-presenting cells.

Zhan HG, Mountz JD, Fleck M, Zhou T, Hsu HC.

Immunol Res. 2002;26(1-3):235-46. Review.

PMID:
12403361
[PubMed - indexed for MEDLINE]
11.

Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells.

Dalton JE, Howell G, Pearson J, Scott P, Carding SR.

J Immunol. 2004 Sep 15;173(6):3660-7.

PMID:
15356111
[PubMed - indexed for MEDLINE]
Free Article
12.

Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand.

Suzuki I, Fink PJ.

J Exp Med. 1998 Jan 5;187(1):123-8.

PMID:
9419218
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.

Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH, Fontana A.

Eur J Immunol. 1995 Aug;25(8):2253-8.

PMID:
7545115
[PubMed - indexed for MEDLINE]
14.

Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice.

Zhang HG, Yang P, Xie J, Liu Z, Liu D, Xiu L, Zhou T, Wang Y, Hsu HC, Mountz JD.

J Immunol. 2002 Apr 15;168(8):4164-72.

PMID:
11937577
[PubMed - indexed for MEDLINE]
Free Article
15.

Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.

Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, Robbins PD.

Mol Ther. 2006 Feb;13(2):289-300. Epub 2005 Nov 7.

PMID:
16275099
[PubMed - indexed for MEDLINE]
16.

Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.

Schwarz A, Grabbe S, Grosse-Heitmeyer K, Roters B, Riemann H, Luger TA, Trinchieri G, Schwarz T.

J Immunol. 1998 May 1;160(9):4262-70.

PMID:
9574528
[PubMed - indexed for MEDLINE]
Free Article
17.

B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.

Bonardelle D, Benihoud K, Kiger N, Bobé P.

J Leukoc Biol. 2005 Nov;78(5):1052-9. Epub 2005 Oct 4.

PMID:
16204618
[PubMed - indexed for MEDLINE]
Free Article
18.

Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.

Nagarkatti N.

Cancer Immunol Immunother. 2000 Apr;49(1):46-55.

PMID:
10782865
[PubMed - indexed for MEDLINE]
19.

Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.

Nakano K, Saito K, Mine S, Matsushita S, Tanaka Y.

Apoptosis. 2007 Jan;12(1):45-54.

PMID:
17136494
[PubMed - indexed for MEDLINE]
20.

Retinoids induce Fas(CD95) ligand cell surface expression via RARgamma and nur77 in T cells.

Tóth B, Ludányi K, Kiss I, Reichert U, Michel S, Fésüs L, Szondy Z.

Eur J Immunol. 2004 Mar;34(3):827-36.

PMID:
14991612
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk